7 completed, 1 not yet recruiting, 1 recruiting. 9 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 7, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Craniotomy: new trials by email Literature Review of Craniotomy trials Research Report on Craniotomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG SBK2-ICG, Craniotomy (Standard of Care) - Malignant Brain Tumors, Glioma | Phase 1 | Not yet recruiting | Tiffany Hodges | 12 | 2026-11-02 | 2026-10-06 |
| Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy Allogeneic Adipose-derived Mesenchymal Stem Cells, Biospecimen Collection, Craniotomy - Recurrent Glioblastoma, IDH-Wildtype, Recurrent Astrocytoma, IDH-Mutant, Grade 4 | Phase 1 | Recruiting | Mayo Clinic | 20 | 2023-06-16 | 2026-04-02 |
| Enhancing Optune Therapy With Targeted Craniectomy Optune, Craniectomy - Glioblastoma | Phase 1 | Completed | Aarhus University Hospital | 15 | 2016-10-01 | 2019-11-27 |
| Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma IGF-1R/AS ODN; Surgery with tissue harvest and implantation 20 diffusion chambers in the rectus sheath with IGF-1R/AS ODN within 24 hours of craniotomy, implanted for 48 hours. - Malignant Glioma, Neoplasms | Phase 1 | Completed | david andrews | 33 | 2015-09-01 | 2025-05-07 |
| Preoperative Chemoradiation for Glioblastoma Temozolomide, partial brain irradiation, stereotactic biopsy of brain tumor - Glioblastoma | Phase 1 | Completed | Tampa General Hospital | 1 | 2014-11-01 | 2015-11-10 |
| Carboplatin in Treating Patients With Recurrent High-Grade Gliomas carboplatin, Surgery - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 | Completed | James Elder | 10 | 2012-06-11 | 2018-07-02 |
| DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas DNX-2401, Tumor Removal - Brain Cancer, Central Nervous System Diseases | Phase 1 | Completed | DNAtrix, Inc. | 37 | 2009-02-01 | 2018-07-16 |
| Oligodendrocyte Progenitor Cell Culture From Human Brain Oligodendrocyte progenitor cell culture/craniotomy - Demyelinating Diseases | Phase 1 | Completed | Department of Medical Services Ministry of Public Health of Thailand | 5 | 2007-12-01 | 2020-10-19 |
| GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma HSPPC-96, Standard Surgical Resection - Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | Completed | University of California, San Francisco | 96 | 2005-11-18 | 2021-05-13 |
Brain Neoplasms (4) · Glioblastoma (4) · Glioma (4) · Astrocytoma (2) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Demyelinating Diseases (1) · Neoplasms (1) · Oligodendroglioma (1)
Aarhus University Hospital (1) · DNAtrix, Inc. (1) · Department of Medical Services Ministry of Public Health of Thailand (1) · James Elder (1) · Mayo Clinic (1) · Tampa General Hospital (1) · Tiffany Hodges (1) · University of California, San Francisco (1) · david andrews (1)
United States (7) · Denmark (1) · Thailand (1)
Alfredo Quinones-Hinojosa, MD (1) · Anders R Korshoej, MD (1) · Frederick F. Lang, MD, BS (1) · James Elder (1) · Jennifer Clarke, MD (1) · Kevin Judy, MD (1) · Lawrence Berk, MD, PhD (1) · Subsai Kongsaengdao, M.D. (1) · Tiffany Hodges, MD (1)
PMID 24335700, PMID 29432077, PMID 30641498, PMID 33500356, PMID 38311852
P50CA097257 (1), R01CA164714 (1)